YTENQ

0.00010.00%
LH

Lynne H. Brum

VP of Planning & Corporate Communications and Secretary

Ms. Lynne H. Brum has been Vice President of Planning and Communications at Yield10 Bioscience, Inc. (formerly known as Metabolix, Inc.) since October 2016 and serves as its Secretary. Ms. Brum served as Vice President of Marketing and Corporate Communications at Yield10 Bioscience, Inc. (formerly known as Metabolix, Inc.) since November 2011 until October 2016. Ms. Brum serves as an Advisor of OnePIN, Inc. She served as an Executive Vice President of Porter Novelli Life Sciences since 2007. She served as Vice President of Strategic Communications of Vertex Pharmaceuticals Incorporated (a holding Company of Aurora Biosciences Corporation) since January 2006 and its Vice President of Corporate communications & Financial Planning from November 2003 to 2006; Vice President of Corporate Development & Communications from December 2001 to 2003; Vice President of Corporate Communications & Market Development since January 2001 and as its Vice President of Corporate Communications from 1998 to January 2001. She joined Vertex Pharmaceuticals Incorporated as Director of Corporate Communications in 1994. She served as Vice President of Feinstein Kean Healthcare. Ms. Brum served in Corporate Communications and research positions at Biogen, Inc. She has 20 years of experience in the areas including corporate branding and positioning, investor relations, scientific and product communications, patient advocacy, crisis communications, M&A communications and employee communications. She served as a Member of the Board of Directors of Altus Pharmaceuticals Inc., from January 2004 to June 9, 2006. Ms. Brum holds an M.B.A. from the Simmons Graduate School of Management and a B.A. in Biological Sciences from Wellesley College.

Positions